Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia

NCT00810667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Cognition

Interventions

DRUG: Lu AE58054
DRUG: Placebo

Sponsor

H. Lundbeck A/S